Concepedia

Publication | Open Access

Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways

DOIFull Paper Access

123

Citations

40

References

2018

Year

Dina S. El‐Agamy, Khaled M. El-Harbi, Saad Khoshhal, Nishat Ahmed, Mohamed A. Elkablawy, Ahmed A. Shaaban, Hany M. Abo‐Haded
Cancer Management and Research

Abstract

This study provides evidence of the cardioprotective activity of Pris which is related to the modulation of Nrf2 and MAPK/NF-kB signaling pathways.

References

YearCitations

Page 1